Metformin+vildagliptin+remogliflozin
About Metformin+vildagliptin+remogliflozin
Metformin+vildagliptin+remogliflozin belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
Metformin+vildagliptin+remogliflozin contains Remogliflozin, Vildagliptin and Metformin. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Vildagliptin works by decreasing the hormones that raise blood glucose levels and increasing insulin release from the pancreas. Together, Metformin+vildagliptin+remogliflozin helps control blood sugar levels.
Metformin+vildagliptin+remogliflozin should be taken as advised by your doctor for a period prescribed it for you, depending on your medical condition. This medicine may cause certain common side effects such as stomach upset, hypoglycaemia, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, if you experience these side effects persistently, consult your doctor on priority.
Metformin+vildagliptin+remogliflozin should be avoided if you are allergic to any of the components in it. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking Metformin+vildagliptin+remogliflozin as it might cause unpleasant side effects. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions. Metformin+vildagliptin+remogliflozin is not recommended for children below 12 years of age as safety and efficacy is not established.
Uses of Metformin+vildagliptin+remogliflozin
Medicinal Benefits
Metformin+vildagliptin+remogliflozin contains Remogliflozin, Vildagliptin and Metformin. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Vildagliptin works by decreasing the hormones that raise blood glucose levels and increasing insulin release from the pancreas. Together, Metformin+vildagliptin+remogliflozin helps control blood sugar levels.
Directions for Use
Storage
Side Effects of Metformin+vildagliptin+remogliflozin
- Stomach upset
- Hypoglycaemia (low blood sugar levels)
- Nausea
- Vomiting
- Diarrhea
- Headache
Patients Concern
Disease/Condition Glossary
Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes; hence it is also known as adult-onset diabetes. Type 2 diabetes symptoms include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, weight loss, and itchy skin.
FAQs
Metformin+vildagliptin+remogliflozin contains Remogliflozin, Vildagliptin and Metformin. Remogliflozin helps in removing excess sugar from the body via urine. Vildagliptin works by decreasing the hormones that raise blood glucose levels and increasing insulin release from the pancreas. Metformin reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body’s sensitivity to insulin. Together, Metformin+vildagliptin+remogliflozin helps control blood sugar levels.
Hypoglycemia/low blood sugar levels could be the side effect of Metformin+vildagliptin+remogliflozin. Hypoglycemia generally occurs when Metformin+vildagliptin+remogliflozin is taken along with other antidiabetic medicines, without food or with alcohol. Consume sugary food such as candy or fruit juice if you experience hypoglycemic symptoms such as dizziness, cold sweats, anxiety, or tremor. Regularly monitor blood glucose levels while taking Metformin+vildagliptin+remogliflozin.
Low-fibre diets, high-fat diets, sugary diets, obesity, smoking, stress, lack of exercise, age, genetic factors, and certain medical conditions are the common causes of diabetes.
